drugset / Trial / NCT02054559
R-CHOP Alone vs. R-CHOP Plus Radiotherapy for Localized CD20+ DLBCL
RandomizedParallel-groupOpen-labelTreatment
Summary
To compare the efficacy and safety of chemotherapy alone and combined modality therapy in the treatment of localized CD20 (+) diffuse large B-cell lymphoma
Timeline
- Start
- —
- Primary completion
- 2020-01
- Completion
- 2020-01
Outcome
Outcome not reported
Stopped: “No consensus among trial centers regarding protocol”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cyclophosphamide | Other / unclassified | — | — |
| Subject | Doxorubicin | Other / unclassified | — | — |
| Subject | Prednisolone | Other / unclassified | — | — |
| Subject | Prednisone | Other / unclassified | — | — |
| Subject | Rituximab | Monoclonal antibody | — | — |
| Subject | Vincristine | Small molecule | — | — |